Ticagrelor bests clopidogrel for reducing stent-thrombosis risk: PLATO

The benefit of ticagrelor appeared independent of baseline variables, such as type of ACS, clopidogrel CYP2C19 genotype, and stent type (bare metal or drug eluting), report investigators.

Source: theHeart.org - August 2, 2013 Category: Cardiology Source Type: news